[Drug therapy of vasculitis with prostaglandins].
D001095:Arachidonic Acids / Q000378:metabolism; D001792:Blood Platelets / Q000378:metabolism; D001808:Blood Vessels / Q000378:metabolism; D011464:Epoprostenol / Q000502:physiology / Q000627:therapeutic use*; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects; D011458:Prostaglandins E / Q000494:pharmacology / Q000627:therapeutic use*; D011465:Prostaglandins, Synthetic / Q000627:therapeutic use; D011928:Raynaud Disease / Q000188:drug therapy; D013931:Thromboxanes / Q000037:antagonists & inhibitors; D014657:Vasculitis / Q000188:drug therapy* / Q000378:metabolism; D014665:Vasodilator Agents
D001095:Arachidonic Acids; D011458:Prostaglandins E; D011465:Prostaglandins, Synthetic; D013931:Thromboxanes; D014665:Vasodilator Agents; C034549:EP 045; D011464:Epoprostenol